HealthPhoto: healthcare-in-europe.comMASLD: Self-Healing Hydrogel Shows Promise as Therapy
Metabolic dysfunction-associated steatotic liver disease (MASLD) affects about 38% of the global population, with cases rising alongside metabolic syndrome. Despite ongoing clinical trials of several drugs, approved treatments remain limited in effectiveness and availability. A self-healing hydrogel is emerging as a promising therapeutic approach for MASLD, potentially offering new options for managing this widespread liver condition.
healthcare-in-europe.com·




